US President Trump had earlier suggested pharmaceutical tariffs could reach 200% after a year, incentivizing domestic manufacturing. On Tuesday, he said that an agreement with India was among the most likely.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/68QMApb
via IFTTT
No comments:
Post a Comment